Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Collegium Pharmaceutical, Inc. (COLL : NSDQ)
 
 • Company Description   
Collegium Pharmaceutical Inc. is a specialty pharmaceutical company. It develops and commercializes prescription and over-the-counter pharmaceuticals for the treatment of central nervous system, respiratory and skin related disorders. The Company's product candidate consists of COL-195, COL-196, COL-171, COL-003 and COL-172 which are in different clinical trial. It developed a formulation platform technology, DETERx, for the treatment of chronic pain. Collegium Pharmaceutical Inc. is based in CUMBERLAND, United States.

Number of Employees: 357

 
 • Price / Volume Information   
Yesterday's Closing Price: $39.06 Daily Weekly Monthly
20 Day Moving Average: 413,714 shares
Shares Outstanding: 31.50 (millions)
Market Capitalization: $1,230.47 (millions)
Beta: 0.63
52 Week High: $42.29
52 Week Low: $23.23
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 5.11% 3.22%
12 Week 31.96% 19.81%
Year To Date 36.33% 21.73%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
100 Technology Center Drive
-
Stoughton,MA 02072
USA		 ph: 781-713-3699
fax: -		 ir@collegiumpharma.com http://www.collegiumpharma.com
 
 • General Corporate Information   
Officers
Vikram Karnani - Chief Executive Officer and President
Michael T. Heffernan - Chairman
Colleen Tupper - Executive Vice President and Chief Financial Offic
Rita Balice-Gordon - Director
Garen G. Bohlin - Director

Peer Information
Collegium Pharmaceutical, Inc. (GSAC)
Collegium Pharmaceutical, Inc. (CASI)
Collegium Pharmaceutical, Inc. (ALCD.)
Collegium Pharmaceutical, Inc. (OMNN)
Collegium Pharmaceutical, Inc. (CGPI.)
Collegium Pharmaceutical, Inc. (CATX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-DRUGS
Sector: Medical
CUSIP: 19459J104
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/25
Next Expected EPS Date: 11/06/25
Share - Related Items
Shares Outstanding: 31.50
Most Recent Split Date: (:1)
Beta: 0.63
Market Capitalization: $1,230.47 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $1.66 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $6.22 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 11/06/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 6.28
Trailing 12 Months: 6.72
PEG Ratio: -
Price Ratios
Price/Book: 5.41
Price/Cash Flow: 3.16
Price / Sales: 1.74
EPS Growth
vs. Year Ago Period: 2.80%
vs. Previous Quarter: 19.51%
Sales Growth
vs. Year Ago Period: 29.41%
vs. Previous Quarter: 5.76%
ROE
06/30/25 - 97.28
03/31/25 - 99.08
12/31/24 - 102.51
ROA
06/30/25 - 13.87
03/31/25 - 15.14
12/31/24 - 16.91
Current Ratio
06/30/25 - 1.18
03/31/25 - 1.08
12/31/24 - 0.95
Quick Ratio
06/30/25 - 1.10
03/31/25 - 1.01
12/31/24 - 0.88
Operating Margin
06/30/25 - 31.98
03/31/25 - 34.09
12/31/24 - 36.60
Net Margin
06/30/25 - 5.13
03/31/25 - 6.61
12/31/24 - 10.96
Pre-Tax Margin
06/30/25 - 7.50
03/31/25 - 9.80
12/31/24 - 15.61
Book Value
06/30/25 - 7.23
03/31/25 - 7.30
12/31/24 - 7.10
Inventory Turnover
06/30/25 - 8.22
03/31/25 - 8.11
12/31/24 - 7.66
Debt-to-Equity
06/30/25 - 3.27
03/31/25 - 3.30
12/31/24 - 3.44
Debt-to-Capital
06/30/25 - 76.56
03/31/25 - 76.73
12/31/24 - 77.49
 

Powered by Zacks Investment Research ©